The misleading use of the term pragmatic in pre-licensing medicine trials Rafael Dal-Ré Editorial 26 March 2019 Pages: 1033 - 1035
The effect of L-carnitine on inflammatory mediators: a systematic review and meta-analysis of randomized clinical trials F. HaghighatdoostM. JabbariMitra Hariri Review 26 March 2019 Pages: 1037 - 1046
Medicine use and medicine-related problems in patients with liver cirrhosis: a systematic review of quantitative and qualitative studies Ejaz CheemaAliaa Al-AryanAbdullah Al-Hamid Review Open access 11 May 2019 Pages: 1047 - 1058
Half-dose ticagrelor versus high-dose clopidogrel in reducing platelet reactivity in acute coronary syndrome patients with high on-clopidogrel platelet reactivity (divide study) Guang Zhong LiuSong ZhangYue Li Clinical Trial 12 May 2019 Pages: 1059 - 1068
Intra- and inter- individual rivaroxaban concentrations and potential bleeding risk in patients with atrial fibrillation Marko MikličAlenka MavriRickard E. Malmström Pharmacodynamics 28 May 2019 Pages: 1069 - 1075
The effect of ketoconazole on praziquantel pharmacokinetics and the role of CYP3A4 in the formation of X-OH-praziquantel and not 4-OH-praziquantel Lovejoy NleyaRoslyn ThelingwaniCollen Masimirembwa Pharmacokinetics and Disposition 15 May 2019 Pages: 1077 - 1087
Population pharmacokinetic analysis of vancomycin in pediatric continuous renal replacement therapy Brady S. MoffettJennifer MorrisAyse Akcan Arikan Pharmacokinetics and Disposition 01 April 2019 Pages: 1089 - 1097
Effect of itraconazole, food, and ethnic origin on the pharmacokinetics of ivosidenib in healthy subjects David DaiHua YangBin Fan Pharmacokinetics and Disposition Open access 23 April 2019 Pages: 1099 - 1108
Pharmacokinetics of venlafaxine in treatment responders and non-responders: a retrospective analysis of a large naturalistic database Georgios SchoretsanitisEkkehard HaenMichael Paulzen Pharmacokinetics and Disposition 09 April 2019 Pages: 1109 - 1116
Medication and medical diagnosis as risk factors for falls in older hospitalized patients Fabian WedmannWolfgang HimmelRoland Nau Pharmacoepidemiology and Prescription Open access 26 March 2019 Pages: 1117 - 1124
Use of prescription drugs in the older adult population—a nationwide pharmacoepidemiological study Line Due ChristensenMette ReilevJanne Petersen Pharmacoepidemiology and Prescription 04 April 2019 Pages: 1125 - 1133
Adverse drug reaction causality assessment tools for drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: room for improvement Jennifer L. GoldmanWen-Hung ChungMunir Pirmohamed Pharmacoepidemiology and Prescription 27 March 2019 Pages: 1135 - 1141
Hepatotoxicity risk factors and acetaminophen dose adjustment, do prescribers give this issue adequate consideration? A French university hospital study Astrid BacleCharlotte PronierLucie-Marie Scailteux Pharmacoepidemiology and Prescription 10 April 2019 Pages: 1143 - 1151
Safety aspects of antiepileptic drugs—a population-based study of adverse effects relative to changes in utilisation Arton BaftiuMaren H. LimaCecilie Johannessen Landmark Pharmacoepidemiology and Prescription 18 April 2019 Pages: 1153 - 1160
Spanish list of potentially inappropriate drugs in the elderly (ES-PIA project) Magali Gonzalez-Colaço HarmandAna María Aldea-PeronaEdmundo Rey Rodríguez Pharmacoepidemiology and Prescription 08 May 2019 Pages: 1161 - 1176
Effects of guggulsterones-containing thermogenic complex on elvitegravir plasma concentrations: a case report Dario CattaneoAnnalisa RidolfoCristina Gervasoni Letter to the Editor 13 April 2019 Pages: 1177 - 1178
Promising effects of moderate-dose corticosteroid therapy in the blanking period for prevention of atrial fibrillation (AF) recurrences in patients undergoing AF ablation Renato De Vecchis Letter to the Editor 23 April 2019 Pages: 1179 - 1180